www.rp.pl · November 13, 2026
Obesity drugs: makers paid PLN 25 million to doctors and organisations
In 2025, two obesity drug makers spent about PLN 25 million on cooperation with doctors, scientific societies and patient organisations. Poles spent nearly PLN 1.5 billion on Mounjaro and Wegovy over the same period. Industry money also stands behind some obesity treatment campaigns.